BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28838717)

  • 1. To Treat or Not to Treat: Role of Immunotherapy in Patients with Concomitant Diagnosis of Advanced-Stage Non-Small Cell Lung Cancer and Psoriasis.
    Khunger M; Calabrese C; Kontzias A; Velcheti V
    J Thorac Oncol; 2017 Sep; 12(9):e147-e149. PubMed ID: 28838717
    [No Abstract]   [Full Text] [Related]  

  • 2. Selecting patients for immune checkpoint inhibition in lung cancer.
    Garon EB
    Clin Adv Hematol Oncol; 2015 Aug; 13(8):490-2. PubMed ID: 26351808
    [No Abstract]   [Full Text] [Related]  

  • 3. Current clinical immunotherapy targets in advanced nonsmall cell lung cancer (NSCLC).
    McCarthy F; Roshani R; Steele J; Hagemann T
    J Leukoc Biol; 2013 Dec; 94(6):1201-6. PubMed ID: 23695306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines and immunotherapy for non-small cell lung cancer.
    Morgensztern D; Goodgame B; Govindan R
    J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S463-5. PubMed ID: 21102240
    [No Abstract]   [Full Text] [Related]  

  • 5. A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials.
    Shaikh SS; Kumthekar PU; Mohindra NA
    J Neurooncol; 2019 Aug; 144(1):235-237. PubMed ID: 31240523
    [No Abstract]   [Full Text] [Related]  

  • 6. [Non-small cell lung cancer: news from immunotherapy].
    Reinmuth N; Heigener DF; Reck M
    Dtsch Med Wochenschr; 2015 Mar; 140(5):329-33. PubMed ID: 25734674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy for non-small cell lung cancer--novel approaches to improve patient outcome].
    Shepherd FA; Douillard JY; Blumenschein GR
    Zhongguo Fei Ai Za Zhi; 2013 Apr; 16(4):C9-20. PubMed ID: 23601304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in immunotherapy for non-small cell lung cancer.
    Reckamp KL
    Clin Adv Hematol Oncol; 2015 Dec; 13(12):847-53. PubMed ID: 27058851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic targets in non-small cell lung cancer: more is more.
    Gnjatic S
    Clin Cancer Res; 2005 Aug; 11(15):5331-2. PubMed ID: 16061843
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.
    Santana-Davila R; Chow LQ
    Future Oncol; 2018 Feb; 14(3):191-194. PubMed ID: 29334785
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy.
    Zheng H; Zeltsman M; Zauderer MG; Eguchi T; Vaghjiani RG; Adusumilli PS
    Immunotherapy; 2017 Sep; 9(11):913-927. PubMed ID: 29338609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine immunotherapy of non-small cell lung cancer.
    Dubinett SM; Kradin RL
    Reg Immunol; 1993; 5(3-4):232-43. PubMed ID: 8240940
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy in the treatment of non-small cell lung cancer.
    Bílek O; Bořilová S; Grell P; Kiss I
    Klin Onkol; 2021; 34(Supplementum 1):54-64. PubMed ID: 34154331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Promise of Neoadjuvant Immunotherapy in Resected Non-small Cell Lung Cancer].
    Yao S; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):55-59. PubMed ID: 31948539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer.
    Kakimi K; Nakajima J; Wada H
    Lung Cancer; 2009 Jul; 65(1):1-8. PubMed ID: 19062127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?
    Rolfo C; Sortino G; Smits E; Passiglia F; Bronte G; Castiglia M; Russo A; Santos ES; Janssens A; Pauwels P; Raez L
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1173-87. PubMed ID: 25148289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nivolumab instills hope in a hopeless situation in advanced nonsmall cell lung cancer with poor performance status.
    Chandrakanth MV; Noronha V; Joshi A; Patil V; Mahajan A; Prabhash K
    Indian J Cancer; 2017; 54(1):55-56. PubMed ID: 29199664
    [No Abstract]   [Full Text] [Related]  

  • 18. [Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer].
    Wang S; Li J
    Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):682-686. PubMed ID: 27760599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunotherapeutic landscape in non-small cell lung cancer and its surgical horizons.
    Rhodin KE; Rucker AJ; Ready NE; D'Amico TA; Antonia SJ
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1616-1623. PubMed ID: 31836182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene immunotherapy for non-small cell lung cancer.
    Nemunaitis JJ
    Methods Mol Biol; 2009; 542():499-514. PubMed ID: 19565919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.